Sanofi Eczema Drug Suits Consolidated, Sent To NJ Fed Court
The Judicial Panel on Multidistrict Litigation has sent to federal court in New Jersey suits against Regeneron Pharmaceuticals and Sanofi-Aventis alleging the eczema drug Dupixent causes a rare type of non-Hodgkin...To view the full article, register now.
Already a subscriber? Click here to view full article